§ BIOTECHNOLOGY
USD · Biotechnology

ALLO

ALLOGENE THERAPEUTICS INC
USDSector · BiotechnologyBeta · 0.55
LAST
n/a
n/aPREV CLOSE · n/a
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX

§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY

13F FLOW
136 increased/new, 52 decreased/exited (13F)
AC 13F Analysis

§ 04 · FUNDAMENTALS · THE BOOKS

P/B1.05EPS (TTM)-0.87
§ 05 · WHO OWNS IT
Top institutional holders
All holders →
FundShares% portΔ Q/Q
Pfizer Inc22.0M20.9%±0%
BlackRock, Inc.19.1M0.0%+8%
TPG GP A, LLC18.7M1.2%±0%
State Street8.7M0.0%+214%
PRIMECAP MANAGEMENT CO/CA/8.4M0.0%+3%
VANGUARD CAPITAL MANAGEMENT LLC6.9Mn/an/a
◇ AC INTELLIGENCE

Top institutional owners for ALLO as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.

§ 06 · WHO OWNS IT · BY STRATEGY

OTHER20.0% · 0 holders
OTHER45.4% · 139 holders
PASSIVE / INDEX10.6% · 10 holders
DEALER / BANK8.7% · 23 holders
QUALITY / COMPOUNDER6.6% · 15 holders
TACTICAL / MACRO4.7% · 5 holders
SYSTEMATIC / QUANT2.3% · 6 holders
ACTIVIST1.1% · 1 holder
INCOME / DEFENSIVE0.4% · 8 holders
GROWTH / MOMENTUM0.1% · 1 holder
◇ AC INTELLIGENCE

Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.

§ 07 · INSIDER ACTIVITY · LAST 180 DAYS

NO INSIDER FILINGS
◇ AC INTELLIGENCE

No Form 4 filings on record for ALLO in the last 180 days.

§ 08 · COVERAGE · OUR RECENT NOTES